MARCIA BELVIN - SVP, Chief Scientific Officer at CytomX Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Scientific Officer
Issuer Symbol
CTMX on Nasdaq
All Insider Reports
All Insider Reports

MARCIA BELVIN - trading volume in the past year for CytomX Therapeutics, Inc.

Holdings reported by MARCIA BELVIN for CytomX Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 272,252 $732,085 $2.69 16 Jun 2025 Direct
Performance Stock Units (PSUs) 18,150 $0 $1.23 26 Sep 2025 Direct Common Stock
Stock Option (Right to Buy) 36,300 26 Sep 2025 Direct Common Stock
Performance Stock Units 0 13 Jun 2025 Direct Common Stock

Transactions reported by MARCIA BELVIN for CytomX Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.